Calidi Biotherapeutics (CLDI) Non Operating Income (2022 - 2025)
Calidi Biotherapeutics' quarterly Non Operating Income came in at $117000.0 in Q4 2025, up 198.32% year-on-year from $39219.7 in Q4 2024, and up 550.0% quarter-over-quarter from $18000.0 in Q3 2025.
Calidi Biotherapeutics has reported Non Operating Income for 4 years, with the latest figure at $117000.0 in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income rose 198.32% year-over-year to $117000.0; the trailing twelve-month figure through Dec 2025 stood at $32000.0 (up 107.58% YoY), and the FY2025 full-year result was $103000.0, up 124.58% from the prior year.
- Non Operating Income for Q4 2025 stood at $117000.0, up from $18000.0 in the prior quarter.
- The five-year high for Non Operating Income was $5.2 million in Q3 2023, with the low at -$1.0 million in Q1 2023.
- Average Non Operating Income over 4 years is $703242.7, with a median of $7000.0 recorded in 2022.
- Year-over-year, Non Operating Income surged 130100.0% in 2023 and plunged 1030.0% in 2025.
- Tracing CLDI's Non Operating Income over 4 years: stood at -$769000.0 in 2022, then jumped by 326.92% to $1.7 million in 2023, then sank by 106.82% to -$119000.0 in 2024, then surged by 198.32% to $117000.0 in 2025.
- The last three Non Operating Income figures came in at $117000.0 (Q4 2025), $18000.0 (Q3 2025), and -$93000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 201.20 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Calidi Biotherapeutics | - | - | - | 117,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 117,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2024 | -119,000.00 |
| Sep 30, 2024 | 156,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | -469,000.00 |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 5.21 Mn |
| Jun 30, 2023 | -16,000.00 |
| Mar 31, 2023 | -1.04 Mn |
| Dec 31, 2022 | -769,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 4.52 Mn |
| Mar 31, 2022 | 1.99 Mn |